Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIVmac251 Env antigen induces neutralizing antibodies and cytotoxic T lymphocyte responses in mice and guinea pigs

AIDS Research and Human Retroviruses

Volumn 13, Issue 18, 1997, Pages 1573-1581

  Eng Mong Lim, ^a   Lagranderie, M ^a   Le Grand, R ^a   Rauzier, J ^a   Gheorghiu, M ^a   Gicquel, B ^a   Winter, N ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; HYBRID PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; VIRUS VECTOR;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENVELOPE GENE; FEMALE; GUINEA PIG; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; INTESTINE MUCOSA; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MYCOBACTERIUM BOVIS; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; SIMIAN IMMUNODEFICIENCY VIRUS; VACCINE PRODUCTION; VIRUS GENE;

EID: 0031459382     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1573     Document Type: Article

References (37)